glp-1 inflammation reduction The Interplay Between GLP-1-Based Therapies, the Gut Microbiome, and MASLD/MASH in Type 2 Diabetes Mellitus: A Narrative Review GLP-1 Agonists: Using Semaglutide, Tirzepatide,

everyday-weight-9-fat-blocker

Add-on Combination Therapy with Glimepiride, with or without Metformin A total of 441 patients with type 2 diabetes participated in a 24-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of Januvia in combination with glimepiride, with or without metformin

It is an exciting frontier in medicine that offers a proactive approach to aging and wellness

A small mark that gets better is different from a bruise that grows, becomes very painful, feels firm and expanding, or appears with other symptoms

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies